Rothblatt Martine A exercised Options for 9,500 United Therapeutics shares and sold 9,500 shares on September 3, 2026. The disclosed exercise and sale price ranges, along with post-transaction holdings of 324,443 shares and 499,410 derivative securities, give investors the transaction’s ownership detail.
Key Highlights
- Rothblatt Martine A held 499,410 United Therapeutics derivative securities after exercising options at $0 per share.
- The share exercises covered two transactions, while the sales were completed through 12 transactions.
- Post-sale direct ownership stood at 324,443 United Therapeutics shares.
Rothblatt Martine A exercised options for 9,500 United Therapeutics shares and sold 9,500 shares in transactions on September 3, 2026. The options were exercised at prices ranging from $117.76 to $135.42 per share, while the sales occurred between $479.07 and $491.25 per share.
United Therapeutics Transactions Span Shares and Options
The share exercises were completed in two transactions under transaction code M. Rothblatt Martine A’s 9,500-share sale was spread across 12 transactions under transaction code S. A separate set of option exercises covered 9,500 derivative securities across two transactions at $0 per share. Following those exercises, Rothblatt Martine A owned 499,410 United Therapeutics derivative securities.
Post-Transaction Ownership Balances
Rothblatt Martine A owned 333,943 United Therapeutics shares after the share exercises. The transaction record separately identifies direct shares and derivative securities, with the latter totaling 499,410 after the option exercises.
FAQs
Q: What did Rothblatt Martine A do in the United Therapeutics insider transaction?
A: Rothblatt Martine A exercised options for 9,500 United Therapeutics shares and sold 9,500 shares on September 3, 2026. The activity covered separate transaction groups.
Q: How did the United Therapeutics insider sale affect Rothblatt Martine A’s holdings?
A: Rothblatt Martine A owned 324,443 United Therapeutics shares after selling 9,500 shares. The post-transaction balance followed earlier exercises covering the same number of shares.
Q: What were Rothblatt Martine A’s option exercise and sale prices?
A: Rothblatt Martine A exercised options at prices ranging from $117.76 to $135.42 per share. The related share sales occurred between $479.07 and $491.25 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.